Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 12 min 13 sec ago

VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer

Thu, 04/07/2016 - 15:16
CE Mark Enables European Clinical Use and Sale in 33 Countries to up to 600 million people NAMUR, Belgium, April 7, 2016 -- (Healthcare Sales & Marketing Network) -- VolitionRx Limited (NYSE MKT: VNRX) today announced CE marking for two blood-based dia...
Diagnostics, Oncology, Regulatory
VolitionRx, NuQ, colorectal cancer

Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors

Thu, 04/07/2016 - 15:11
MISSISSAUGA, ON, April 7, 2016 -- (Healthcare Sales & Marketing Network) - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Rosemary A. (Rose) Crane and Dr. Renee P. Tannenbaum, two ph...
Biopharmaceuticals, Dermatology, Personnel
Cipher Pharmaceuticals

Paul Hawthorne appointed Senior Vice President, U.S. Commercial, Neurology Business Group at Eisai Inc.

Wed, 04/06/2016 - 15:19
WOODCLIFF LAKE, N.J., April 6, 2016 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced the immediate appointment of Paul Hawthorne to the position of Senior Vice President, U.S. ...
Biopharmaceuticals, Neurology, Personnel
Eisai

Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer

Wed, 04/06/2016 - 15:10
RARITAN, N.J., April 6, 2016 -- (Healthcare Sales & Marketing Network) -- Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today it has entered a worldwide collaboration and license agreement with TESARO, ...
Biopharmaceuticals, Oncology, Licensing
Janssen, Johnson & Johnson, TESARO, niraparib, breast cancer, ovarian cancer

Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction

Wed, 04/06/2016 - 15:06
Pfizer-Allergan Merger Agreement Terminated Allergan's Leading Commercial Franchises, 70+ Mid-to-Late Stage Pipeline Projects to Fuel Continued Strong Top-Line Growth in 2016 and Beyond Powerful Financial Profile and Balance Sheet Provides Optionalit...
Biopharmaceuticals, Mergers & Acquisitions
Allergan, Pfizer

Pfizer Announces Termination of Proposed Combination with Allergan

Wed, 04/06/2016 - 15:04
NEW YORK, NY--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) today announced that the merger agreement between Pfizer and Allergan plc (AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announc...
Biopharmaceuticals, Mergers & Acquisitions
Pfizer, Allergan

Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients

Wed, 04/06/2016 - 15:02
Novel liquid biopsy RAS testing now available to clinical practices for metastatic colorectal cancer (mCRC) patients The test will help guide physicians to select the most effective treatment for mCRC patients in a timely manner DARMSTADT, Germany, ...
Diagnostics, Oncology, Regulatory
Merck, Sysmex Inostics, OncoBEAM, colorectal cancer

Sorrento Appoints Kevin M. Herde As Chief Financial Officer

Wed, 04/06/2016 - 14:57
SAN DIEGO, April 5, 2016 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (SRNE), an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases, today annou...
Biopharmaceuticals, Personnel
Sorrento Therapeutics, resiniferatoxin

Premia Spine Launches ProMIS(TM) Fixation System

Tue, 04/05/2016 - 13:37
First Skin-to-Screw Pedicle Screw Placement System with sterile-pack implants PHILADELPHIA, April 5, 2016 -- (Healthcare Sales & Marketing Network) -- Premia Spine, a spinal implant company focused on commercializing innovative lumbar solutions, today ...
Devices, Orthopaedic, Neurosurgery, Product Launch
Premia Spine, ProMIS Fixation System, Pedicle Screw, spine surgery

Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis

Tue, 04/05/2016 - 13:30
NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. announced today top-line results from its first Phase 3 study investigating tofacitinib for the treatment of psoriatic arthritis, Oral Psoriatic Arthritis triaL (OPAL) Broaden. This study evalua...
Biopharmaceuticals
Pfizer, tofacitinib, XELJANZ, psoriatic arthritis

Ability Dynamics Introduces the Dynamic, Ultra Low Profile RUSH ROVER(TM) for Active Amputees

Tue, 04/05/2016 - 13:19
TEMPE, Ariz., April 5, 2016 -- (Healthcare Sales & Marketing Network) -- Ability Dynamics, LLC a developer of next-generation prosthetic devices announced today the release of the ultra low profile RUSH ROVER™ prosthetic foot. Determined to remain at t...
Devices, Orthopaedic, Product Launch
Ability Dynamics, RUSH ROVER, prosthetic foot

Braeburn Pharmaceuticals and Camurus Announce Enrollment Goals Reached in Two Pivotal Phase 3 Trials of Cam2038 for Treatment of Opioid Dependence

Tue, 04/05/2016 - 13:11
PRINCETON, N.J. and LUND, Sweden, April 5, 2016 -- (Healthcare Sales & Marketing Network) -- Braeburn Pharmaceuticals and Camurus today announced that the enrollment goals for both the 24-week efficacy study and the 48-week safety study were met on 31 Mar...
Biopharmaceuticals
Braeburn Pharmaceuticals, Camurus, CAM2038, Opioid Dependence

Therabron Therapeutics Appoints Eric Richman as an Independent Board Member

Mon, 04/04/2016 - 20:08
ROCKVILLE, Md., April 4, 2016 -- (Healthcare Sales & Marketing Network) -- Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced the appointment of Eric I. Richman a...
Biopharmaceuticals, Personnel
Therabron Therapeutics

First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON(R) (sulfur hexafluoride lipid-type A microspheres) for Injectable Suspension, for Intravenous Use

Mon, 04/04/2016 - 20:06
MONROE TOWNSHIP, N.J., April 4, 2016 -- (Healthcare Sales & Marketing Network) -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business, announced today that LUMASON ...
Biopharmaceuticals, Radiology, FDA
Bracco Diagnostics, LUMASON, SonoVue, sulfur hexafluoride, imaging

Eiger BioPharmaceuticals Strengthens Board of Directors with Addition of Industry Veteran Charles J. "Chuck" Bramlage

Mon, 04/04/2016 - 19:59
PALO ALTO, Calif., April 4, 2016 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc, (NASDAQ: EIGR) announced today that its Board of Directors has appointed Charles J. "Chuck" Bramlage as a member of the Board. Mr. B...
Biopharmaceuticals, Personnel
Eiger BioPharmaceuticals

ANI Pharmaceuticals Closes Acquisition of Inderal(R) LA Assets

Mon, 04/04/2016 - 19:57
BAUDETTE, Minn., April 4, 2016 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today announced that it has completed the acquisition of the portfolio of Inderal® LA assets from Cranford Pharmaceuticals, ...
Biopharmaceuticals, Cardiology, Acquisitions
ANI Pharmaceuticals, Cranford Pharmaceuticals, Inderal, propranolol

Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development

Mon, 04/04/2016 - 17:55
MISSISSAUGA, ON, April 4, 2016 -- (Healthcare Sales & Marketing Network) - Nuvo Pharmaceuticals Inc. (NRI.TO) (Nuvo or the Company) today announced that Jesse Ledger has been appointed to the newly created position of Vice President, Business Development....
Biopharmaceuticals, Personnel
Nuvo Pharmaceuticals, Pennsaid

AbbVie Receives CHMP Positive Opinion for HUMIRA(R) (adalimumab) for the Treatment of Pediatric Patients, from Six Years of Age, with Moderately to Severely Active Crohn's Disease

Mon, 04/04/2016 - 13:36
Pediatric Crohn's disease is a chronic, inflammatory condition of the gastrointestinal tract that can have a substantial physical and psycho-social impact. NORTH CHICAGO, Ill., April 4, 2016 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a...
Biopharmaceuticals, Gastroenterology, Regulatory
AbbVie, Crohn's disease, HUMIRA, adalimumab

BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval

Mon, 04/04/2016 - 13:30
TEL AVIV, Israel, April 4, 2016 -- (Healthcare Sales & Marketing Network) -- BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced today that its partner, Omega Pharma, now part of Perrigo, has received CE Mark approval for BL-5010 as a novel OTC treatment for the...
Biopharmaceuticals, Dermatology, Regulatory
BioLineRx, Omega Pharma, Perrigo, BL-5010

Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients

Mon, 04/04/2016 - 13:23
First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7 RICHMOND, Calif., April 04, 2016 -- (Healthcare Sales & Marketing Network) -- Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced th...
Devices, Neurology, FDA
Ekso Bionics, robotic exoskeleton, Ekso GT, stroke

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong